Starpharma Holdings Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Starpharma Holdings stock has an average price target of $1.22. The average 1-year stock price forecast is 62.67% higher than the current stock price, while the lowest is $1.19 (+58.67%) and the highest is $1.25 (+66.67%).

Price Target: $1.22 (+62.67%)

Analyst Consensus: n/a

Price Target

Chart

Target	Low	Average	Median	High
Price	$1.19	$1.22	$1.22	$1.25
Change	+58.67%	+62.67%	+62.67%	+66.67%

Analyst Ratings

According to 1 stock analyst, the rating for Starpharma Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Jan '26	Apr '26	Aug '26	Sep '26
Strong Buy	1	1	1	1	1
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	1	1

Financial Forecast

Revenue This Year

24.00M

from 12.67M

89.45%

from 12.67M

Revenue Next Year

37.50M

from 24.00M

56.25%

from 24.00M

EPS This Year

0.00

from -0.02

EPS Next Year

0.03

from 0.00

1,350.00%

from 0.00

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	5.16M	4.34M	9.76M	5.85M	12.67M	24.00M
Revenue Growth	48.04%	-15.87%	124.64%	-40.04%	116.55%	89.45%
Operating Income	-16.15M	-15.64M	-8.17M	-9.99M	-7.47M	100.00K
Net Income	-16.15M	-15.64M	-8.17M	-9.99M	-7.47M	1.20M
EPS	-	-	-	-	-0.02	0.00
Forward PE	34.94	34.94	34.94	34.94	34.94	375.00
Free Cash Flow	-	-	-	-	-2.92M	-1.10M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	24.0M
Avg	24.0M
Low	24.0M

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	89.5%
Avg	89.5%
Low	89.5%

EPS Forecast

Chart

EPS	2027	2028	2029
High	0.00
Avg	0.00
Low	0.00

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-